Two suspected cases of Guillain-Barré Syndrome (GBS) have been found in the Delhi National Capital Region (NCR), according to ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

Every year, thousands of people die from overdosing on opioids in the United States. But a new non-opioid pain medication, ...

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

The Vilcek Foundation awarded the 2025 Prizes in Biomedical Science to Marianne Bronner, Elham Azizi, Guosong Hong, and Maayan Levy.

The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...

Christian Fellowship Center Lead Pastor Brian Dube is making a miraculous recovery from a case of near-fatal paralysis from a ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

CHENNAI: After a nine-year-old boy from Thirvur in Tiruvallur district died due to Guillain-Barre Syndrome (GBS) — a rare ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.